Also trades as: BIO-B (NYSE) · $vol 0M
BIO NYSE
Bio-Rad Laboratories, Inc.
1W: +7.4%
1M: +0.8%
3M: +16.4%
YTD: +24.8%
1Y: +12.1%
3Y: +22.5%
5Y: -48.0%
$380.99
+8.56 (+2.30%)
Weekly Expected Move ±4.9%
$334
$352
$370
$388
$406
Credit Risk of going bust: lower than 70% of companies Debt: 10.6% of company value Bonds: $41.6M held by 57 funds, 79 bp over Treasuries → details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $4.63 (down 99%), Bio-Rad Laboratories, Inc. would be worth roughly what it owes.
Total debt $1.20B against a stock market value of $10.19B.
Distance to default 7.62 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $802.2M (short-term plus half of long-term), stock volatility 36.7%; Altman Z 3.86. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
If the stock fell to about $4.63 (down 99%), Bio-Rad Laboratories, Inc. would be worth roughly what it owes.
Total debt $1.20B against a stock market value of $10.19B.
Distance to default 7.62 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $802.2M (short-term plus half of long-term), stock volatility 36.7%; Altman Z 3.86. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
1 relationships0
As Filer
counterparties named
1
As Counterparty
mentioned by others
2024-04-11
Earliest Filing
2024-04-11
Latest Filing
Mentioned As Counterparty
1 mentionsOther companies that named BIO in their SEC 8-K filings.
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-04 | Earnings Release; Exit/Disposal Costs; Regulation FD; Exhibits | View | |
| 2026-04-30 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-04-24 | Officer/Director Change; Shareholder Vote; Exhibits | View | |
| 2026-02-19 | Regulation FD Disclosure | View | |
| 2026-02-12 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-10-29 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-09-30 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-08-26 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-07-31 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-07-28 | Departure/Election of Directors; Appointment of Officers; Other Events; Financial Statements and Exh | View | |
| 2025-06-30 | Other Events | View | |
| 2025-05-01 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-04-25 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-02-21 | Regulation FD Disclosure | View | |
| 2025-02-13 | Results of Operations and Financial Condition; Costs Associated with Exit or Disposal Activities; Ot | View | |
| 2024-10-30 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-09-09 | Amendments to Articles of Incorporation or Bylaws; Financial Statements and Exhibits | View | |
| 2024-08-20 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2024-08-01 | Results of Operations and Financial Condition; Other Events; Financial Statements and Exhibits | View | |
| 2024-05-07 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR